MedPath

Comparison of the Hemodynamic Effects of Ketamine - Dexmedetomidine (Ketodex) Versus Propofol-ketamine Admixture (Ketofol) During Induction of Anesthesia in Elderly: A Randomized Controlled Study.

Not Applicable
Recruiting
Conditions
Ketamine-dexmedetomidine Induction of Anesthesia
Interventions
Drug: ketamine-dexmedetomidine admixture induction of Anesthesia
Registration Number
NCT07002073
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

To compare the hemodynamic effects of Ketamine-Dexmedetomidine admixture (Ketodex) versus propofol-ketamine admixture (Ketofol) during induction of anesthesia in elderly

Detailed Description

This study details the protocol for anesthetic induction and maintenance, allocating patients into Ketodex (KD) and Ketofol (KP) groups. Prior to anesthesia, a fluid challenge (4 mL/kg over 10 minutes) was administered to assess volume status, with repeated challenges until pulse pressure increased by less than 15% of baseline. For induction, all patients received 1 mg/kg lidocaine. KD patients then received 1 mg/kg ketamine + 0.5 µg/kg dexmedetomidine over 10 minutes, while KP patients received 0.15-0.20 mL/kg of a ketofol admixture. Loss of consciousness, defined by no response to auditory commands and absent eyelash reflex, led to the administration of 0.6 mg/kg rocuronium. After 2 minutes of mask ventilation, an endotracheal tube was inserted. Anesthesia was maintained with isoflurane (0.9-1% end-tidal), and Ringer's lactate solution was infused at 4 mL/kg/hour. Hemodynamic stability was rigorously managed: hypotension (mean blood pressure (MBP) ≤ 80% of baseline and/or MBP \< 60 mmHg) occurring up to 15 minutes post-intubation or skin incision was treated with 5 µg norepinephrine boluses, repeatable every 2 minutes. Severe post-induction hypotension (MBP ≤ 60% of baseline) prompted 5 µg norepinephrine boluses every minute, with 1-minute interval blood pressure monitoring. Hypertension (mean arterial pressure \> 120% of baseline) was managed with 0.25 mg/kg IV propofol, while bradycardia (heart rate \< 45 bpm) was treated with 0.5 mg IV atropine. Blood pressure and heart rate were continuously monitored at specified intervals, with subsequent hemodynamic management left to the discretion of the attending anesthetist after 15 minutes post-intubation or skin incision.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Participants will be elderly patients (>65 years), ASA I-III, scheduled for elective non-cardiac surgery under general anesthesia.
Exclusion Criteria
  • Patients with severe cardiac morbidities (impaired contractility with ejection fraction < 50%, heart block, arrhythmias, tight valvular lesions, metabolic equivalent [MET] less than 4, patients on angiotensin converting enzyme inhibitors and angiotensin receptor blockers medications, patients with uncontrolled hypertension, patients undergoing adrenalectomy, patients with body mass index <18 or > 35 Kg/m2), patient with allergy of any of the study drugs will be excluded from the study and if the patient is considered to be difficult intubation in preoperative assessment will be excluded as well.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ketamine-dexmedetomidine admixture induction of Anesthesiaketamine-dexmedetomidine admixture induction of Anesthesia-
propofol - ketamine admixture induction of Anesthesiaketamine-dexmedetomidine admixture induction of Anesthesia-
Primary Outcome Measures
NameTimeMethod
Incidence of post-induction hypotension12 months

Incidence of post-induction hypotension (MBP ≤80% of baseline or \<60 mmHg) during the period from induction of anesthesia until 16-minutes after intubation providing that skin incision will be after 16-minutes interval.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo University Hospitals

🇪🇬

Cairo, Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath